Related Experiment Video
Updated: Jun 18, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Indications and clinical outcomes for below knee endovascular therapy: review article
Lanfroi Graziani1, Alberto Piaggesi
1Invasive Cardiology Unit, Istituto Clinico Città di Brescia, Brescia, Italy. lanfroi.graziani@grupposandonato.it
Insights
Peripheral revascularization for critical limb ischemia (CLI) is vital. Below-knee (BK) endovascular therapy can reduce amputations and mortality, despite high restenosis rates, especially in diabetic patients.
Area of Science:
- Vascular Surgery
- Endovascular Interventions
- Diabetology
Background:
- Chronic critical limb ischemia (CLI) is a leading cause of amputation.
- Below-knee (BK) artery revascularization is often under-evaluated before amputation.
- Diabetic foot syndrome presents unique challenges in CLI management.
Purpose of the Study:
- To review indications and clinical outcomes of BK endovascular therapy.
- To highlight the impact of diabetes mellitus on CLI treatment.
- To clarify the role and effectiveness of endovascular treatment in BK arteries.
Main Methods:
- Review of existing literature on BK endovascular therapy for CLI.
- Analysis of clinical outcomes, including patency, limb salvage, and mortality.
- Focus on the specific characteristics and outcomes in diabetic patients.
Main Results:
- BK endovascular therapy can reduce major amputation rates and mortality.
- High rates of restenosis are observed, while ulcer healing and limb salvage rates are often low.
- Clinical benefit may not directly correlate with primary patency rates.
Conclusions:
- Despite challenges like high restenosis, BK endovascular therapy positively impacts CLI outcomes.
- Revascularization is crucial for reducing mortality in CLI patients, particularly through amputation reduction.
- Understanding the role of diabetes is essential for optimizing BK endovascular therapy.
Abstract:
Chronic critical limb ischemia (CLI) still represents the most common cause for amputation and frequently the possibility for peripheral revascularization, particularly in below knee (BK) arteries, is not adequately evaluated before amputation. This may also be due to the fact that even today, there's some confusion about results of the endovascular treatment in this territory. Diabetics, representing the population most frequently affected by CLI, have specific clinical characteristics, the so called diabetic foot syndrome, which cannot be compared with the situation in nondiabetic patients with ischemic ulcers. Measuring the success of BK endovascular therapy can be a difficult issue, considering that it is often the work of a multidisciplinary team. The clinical benefit of BK endovascular therapy often shows a large discrepancy from the primary patency. While ulcer healing, limb salvage, and reintervention rates are usually low after BK endovascular therapy, rates of restenosis remain excessively high. Nevertheless, the positive impact of revascularization on mortality, which mainly depends on the major amputation rate reduction, is also evident. This review article summarizes indications and clinical outcomes after BK endovascular therapy with special attention to the role of diabetes mellitus in patients with CLI.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease V: Postoperative Nursing Management
